ARIA:
Analysis & Opinions
-
January 30, 2013
ARIAD Pharmaceuticals, Inc. (ARIA) recently announced the closure of its previously announced public offering. ARIAD ...
-
December 17, 2012
On a good day for the market, the Nasdaq has risen 0.5%, the S&P 500 has increased 0.6% and the Dow has moved up ...
-
December 17, 2012
ARIAD Pharmaceuticals (ARIA) recently announced positive data from the pivotal PACE study on ponatinib. ARIAD is ...
-
December 05, 2012
Jazz Pharmaceuticals (JAZZ) recently initiated a study on Erwinaze (asparaginase Erwinia chrysanthemi) for the ...
-
November 30, 2012
ARIAD Pharmaceuticals (ARIA) recently announced the publishing of results from a phase I dose-escalation study of ...
-
October 02, 2012
ARIAD Pharmaceuticals, Inc. (ARIA) recently completed the rolling submission of the New Drug Application (NDA) for ...
-
September 19, 2012
ARIAD Pharmaceuticals, Inc. (ARIA) and its diagnostic collaborator, the privately held MolecularMD Corporation ...
-
August 31, 2012
ARIAD Pharmaceuticals, Inc. (ARIA) recently submitted a Marketing Authorization Application (MAA) for its BCR-ABL ...
-
June 06, 2012
Merck (MRK) recently received a complete response letter (CRL) from the US Food and Drug Administration (FDA) for ...
-
March 26, 2012
One of the clearest sentiment indicators comes from short sellers. Changes in the number of shares shorted over time ...
-
December 27, 2011
Investors found huge winners in Hepatitis C and cancer this year.
-
July 05, 2011
Check out June's Best Performing Healthcare Stocks!
-
May 27, 2010
ASCO is a major event for the pharmaceutical and biotech industry, and these stocks could shine in the limelight.
-
August 12, 2009
The Biotechnology industry is starting to raise capital again as the markets loosen up, and investors remain ...
